Home > News > featured news > Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions Through AI and Machine Learning Technology

AI

Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions Through AI and Machine Learning Technology

Surgio | December 01, 2021

AI and Machine Learning Technology for Healthcare

Surgio Health, a leading healthcare software platform targeting instrument tracking and optimization solutions, has partnered with DARVIS (Data Analytic Real-World Visual Intelligence System), a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.

DARVIS is a productivity as a service platform (PaaS) that digitizes objects and processes through AI-powered computer vision technology, enabling it to provide real-time analysis of environments and situations. With the use of computer vision technology, healthcare providers can now easily track objects such as surgical instruments, no matter how small. This allows for tracking and optimization down to the instrument level without the need to individually tag each item.

Surgio Health is a software as a service platform (SaaS) that provides a fully integrated digital transformation of surgical asset management and optimization for the operating room (OR) and sterile processing department (SPD). With Surgio, facilities can easily locate surgical instruments, ensure proper sterilization steps are taken, coordinate with vendors for loaned and consigned instrument sets, and use interactive analytics to reduce costs and improve productivity.

Using DARVIS's computer vision technology, the two will be able to incorporate the use of AI tracking cameras with Surgio's innovative and in-depth tracking software. With the creation of this partnership, the OR and SPD will be able to manage and optimize their sterilization costs, staffing models, and case readiness.

"DARVIS is thrilled to join forces with Surgio to bring the next age of innovation to healthcare. Our Inventory Tracker platform adds visibility to Surgio's robust existing tracking software. The Inventory Tracker solution can track surgery kits and scopes throughout the equipment's entire lifecycle. This directly translates to immediate boosts in efficiency standards and cost savings." - Jan Schlueter, COO, DARVIS

"Surgio is very excited to partner with DARVIS for the development of transformative Artificial Intelligence through optical recognition and machine learning solutions. Together we will bring actionable data insights that provide real-time visibility and predictability of surgical equipment and staffing optimization to the OR and SPD departments."

Chris J. Stewart, CEO, Surgio Health

Instrument level tracking becomes even easier with machine learning. Eliminating the need to tag individual instruments makes implementation painless and cost-effective for any hospital system. Surgio and DARVIS will begin by tracking endoscopes, which are often one of the most challenging—and costly—instruments to track and sterilize effectively, with undetectable bioburden frequently remaining in tough-to-clean areas. Through DARVIS's visual tracking system, Surgio can ensure that these scopes are systematically sterilized properly, without additional work being placed on employees.

Together, DARVIS and Surgio want to eliminate patient safety risks and unnecessary processing costs related to sterilization, while simplifying process and workflow for hospitals and their staff. Currently, the two companies plan to release their first partnership solution in 2022.

About Surgio

Surgio Health is a surgical instrument management technology partner for healthcare facilities and medical device manufacturers. Surgio delivers an innovative suite of solutions that drive alignment between OR, sterile processing department (SPD), surgeons, and vendors to lower costs, mitigate risk, and improve efficiencies. Our surgical instrument tracking & optimization, vendor performance management, and manufacturer & distributor asset management solutions follow HIPAA guidelines and are EHR/ERP integrated. Founded in 2015, the company is based in Scottsdale, Arizona.

About DARVIS

DARVIS (Data Analytic Real-World Visual Intelligence System) is a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. DARVIS solutions help transform hospitals and healthcare organizations into intelligent autonomous environments that enable healthcare professionals to deliver better and safer patient-centric care. Founded in 2015, the company is based in Nashville, Tennessee.

Spotlight

Healthcare Use cases using EON AI Assistant

EON Reality’s 23 years of success are tied to its belief that knowledge is a human right and should be available, accessible, and affordable for every human on the planet.

More featured news

Spotlight

Healthcare Use cases using EON AI Assistant

EON Reality’s 23 years of success are tied to its belief that knowledge is a human right and should be available, accessible, and affordable for every human on the planet.

Related News

HEALTH TECHNOLOGY, HEALTHTECH SECURITY

Origami Risk Announces Its New Employee Health Information Solution

Origami Risk | March 01, 2023

On February 28, 2023, one of the top safety, risk and insurance software companies, Origami Risk, announced the launch of a latest employee health information solution for managing and centralizing drug, vaccination details and alcohol screening results, and other records related to pre-hire, post-exposure or ongoing screening health assessments required by employers. The new capabilities, which can be easily integrated with an employer's existing HRIS, are an expansion of the technology company's single-platform risk management information system (RMIS); healthcare risk management; environmental, health, and safety (EHS) solutions; and well-known prior-generation COVID-19 solution suite. Utilizing the Origami Risk platform's online portal functionality, configurable screens and dashboards, automated workflow engine, and integrated reporting, the solution supports risk management, employee health, and safety professionals, as well as others tasked with ensuring compliance with organizational policies and regulatory requirements for participant (i.e., employee, candidate, contractor, volunteer) health and safety. The latest employee health solution enables organizations for Collect, assign and document the results of required tests and screening, including alcohol testing and drug, vision and hearing assessments, tuberculosis (TB) testing, respirator fit testing and post-injury or post-exposure medical evaluations. Track employee immunizations, including proof of completion (e.g., influenza, hepatitis B) and COVID-19 vaccinations, boosters, and waivers. Automate logistics for testing and exposure management (e.g., notifications and reminders). • Search, locate, and view employees' testing, screening, and vaccination records, as well as any attached documents. Observe testing, screening and vaccination metrics like rate of compliance. About Origami Risk Origami Risk is one of the top providers of integrated risk, safety, compliance, healthcare, and P&C insurance SaaS solutions. It provides its highly configurable GRC, RMIS, EHS and healthcare risk management solutions from a scalable, secure platform that includes work tools for automating critical workflows, centralizing data, and providing insights into safety and risk initiatives. Its cloud-based software is designed to meet the needs of multiple sectors within the insurance and risk marketplace. Origami Risk was founded in 2009 by industry veterans who recognized the need for a single-version, cloud-based RMIS platform. Since then, the company has expanded its product offerings and grown to more than 500 employees providing software and support to over 500 companies worldwide.

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

CCS Introduces Scientific Advisory Council to Advance Chronic Care Management

CCS | February 02, 2023

On February 1, 2023, CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced the launch of its Scientific Advisory Council, comprised of four industry leaders who will assist CCS in its commitment to reinventing patient care at home through a more holistic approach. The Council consists of Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Alexander Ding, MD, MBA; Steven Wittlin, MD; and Francine Kauffman, MD. This announcement follows the appointment of Arti Masturzo, MD, as CCS's first Chief Medical Officer. Over 11% of the US population has been diagnosed with diabetes, which is projected to increase among American youth and young adults. Therefore, there is a great need for innovative technologies, partnerships, and services to fully support people in managing their diabetes. CCS chose to assemble its Scientific Advisory Council and assume a leadership position in redefining how health plans, providers, and employers support their patients and members impacted by costly, debilitating chronic diseases. Additional information about the initial members of the Council is provided below • Alexander Ding, MD, MBA, is a diagnostic and interventional radiologist, Associate VP of Physician Strategy and Medical Affairs for Humana, and an American Medical Association board member. He cultivates physician-health plan relationships and patient empowerment and engagement through digital health. • Karmeen Kulkarni, MS, CD, RD, CDCES, BC-ADM, is a clinical pioneer in diabetes management with over 30 years of experience. She was Abbott's Global Scientific Affairs director for 15 years before starting her consulting firm. Ms. Kulkarni has unique experience integrating devices, technology, coaching, and clinical services to improve outcomes for diabetes patients. • Steven Wittlin, MD, is an endocrinologist, published author, and University of Rochester's Director of Diabetes Services. His experience includes new diabetes treatment procedures that combine best practices in technology, medical devices, and clinical services. • Francine Kaufman, MD, a pediatric endocrinologist, and former American Diabetes Association president, is the Chief Medical Officer at Senseonics, Inc., and previously held that position at Medtronic Diabetes. Dr. Kaufman, a key CCS Strategic Advisory Board member, will also be on the Scientific Advisory Council. About CCS Based in Dallas, Texas, CCS provides collaborative care programs and medical supplies delivered at home for people with chronic conditions, particularly diabetes. As a result, patients have better probabilities of starting and continuing therapy with CCS as their partner, lowering costs and enhancing outcomes. The company serves over 150,000 people in the United States with chronic conditions and delivers over 1.2 million medical products to homes yearly. With over 25 years of experience, CCS has the expertise, data, and relationships to usher in a new era of home-based, proactive chronic care management.

HEALTHTECH SECURITY, DIGITAL HEALTHCARE

CHA Hollywood Presbyterian Medical Center Launches Fetal Surgery Program

CHA Hollywood Presbyterian Medical Center | January 23, 2023

Hollywood Presbyterian Medical Center (CHA HPMC), a member of CHA Health Systems, recently announced a new partnership with Los Angeles Fetal Surgery to provide life-saving and revolutionary fetal surgery to pregnant women and their unborn babies with birth defects. It will be the only fetal surgery center in the U.S. Los Angeles Fetal Surgery, a joint program between USC and Children's Hospital Los Angeles, offers minimally invasive fetal treatments to reduce or cure adverse outcomes due to fatal conditions, which would otherwise result in the baby's death or irreversible organ damage. Dr. Ramen Chmait, an international expert in minimally invasive fetal surgery, will direct the program. He has produced over 200 manuscripts and book chapters in fetal medicine and surgery over the past 20 years. "The goal of the Los Angeles Fetal Surgery Program at CHA Hollywood Presbyterian is to treat unborn babies with innovative treatments while providing families with emotional support," said Ramen Chmait, MD, who also serves as an OB-GYN with Keck Medicine of USC. (Source- Business Wire) "Our collaborative structure ensures our patients have access to a wide variety of services and specialists. This affiliation with CHA HPMC only strengthens our commitment to successful outcomes,” he further added. (Source- Business Wire) According to the CDC, 1 in 33 U.S. newborns is born with a serious condition. The program will treat Spina Bifida, Vasa Previa, and Twin-Twin Transfusion Syndrome. CHA HPMC, Los Angeles' second-largest maternity center, provides excellent prenatal and postpartum care. Fetal surgery will help CHA HPMC serve its community and improve results for expectant families. About CHA Hollywood Presbyterian Medical Center CHA Hollywood Presbyterian Medical Center (CHA HPMC) is a full-service hospital, providing acute care to the multicultural population of Hollywood and its neighboring regions since 1924. CHA Bio Group is known worldwide for its high-quality health care and advances in reproductive medicine. CHA HPMC has 469 acute care beds and 89 skilled nursing beds. The hospital employs about 550 doctors from 69 disciplines and 75 nationalities. It treats its various multicultural patients with kindness and compassion. CHA Health Systems, a dynamic global healthcare corporation with 86 hospitals and clinics, 30 research and 14 education institutes, along with 31 bio/pharmaceutical/healthcare enterprises, provides a wide range of services in seven countries.